BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12067279)

  • 1. Correlation between the uptake of Tc-99m-sestaMIBI and prognostic factors in patients with multiple myeloma.
    Alexandrakis MG; Kyriakou DS; Passam FH; Malliaraki N; Christophoridou AV; Karkavitsas N
    Clin Lab Haematol; 2002 Jun; 24(3):155-9. PubMed ID: 12067279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
    Alexandrakis MG; Kyriakou DS; Passam F; Koukouraki S; Karkavitsas N
    Ann Hematol; 2001 Jun; 80(6):349-53. PubMed ID: 11475149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patterns.
    Bacovsky J; Myslivecek M; Scudla V; Koranda P; Buriankova E; Minarik J; Pika T; Zapletalova J
    Clin Nucl Med; 2010 Sep; 35(9):667-70. PubMed ID: 20706038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
    Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
    Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
    Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
    Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
    Ak I; Aslan V; Vardareli E; Gülbaş Z
    Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma.
    Bacovsky J; Scudla V; Myslivecek M; Nekula J; Vytrasová M
    Neoplasma; 2005; 52(4):302-6. PubMed ID: 16059646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System.
    Koutsikos J; Grigoraki V; Athanasoulis T; Velidaki A; Mamoulakis C; Zomas A; Anagnostopoulos N; Georgiou E; Dimopoulos MA; Zerva C
    Hell J Nucl Med; 2006; 9(3):177-80. PubMed ID: 17160159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
    Pace L; Catalano L; Pinto A; De Renzo A; Di Gennaro F; Califano C; Del Vecchio S; Rotoli B; Salvatore M
    Eur J Nucl Med; 1998 Jul; 25(7):714-20. PubMed ID: 9662593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
    Myslivecek M; Nekula J; Bacovsky J; Scudla V; Koranda P; Kaminek M
    Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of 99mTc-MIBI whole body scintigraphy in active and in remission multiple myeloma.
    Fallahi B; Saghari M; Fard Esfahani A; Eftekhari M; Iravani M; Beiki D; Dabbagh Kakhki VR; Sadeghi R
    Hell J Nucl Med; 2005; 8(3):165-8. PubMed ID: 16390023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi.
    Castellani M; Carletto M; Baldini L; Calori R; Longari V; Soligo D; Dellavedova L; Gerundini P
    Clin Nucl Med; 2010 Jan; 35(1):1-5. PubMed ID: 20026963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
    Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
    Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
    Fonti R; Del Vecchio S; Zannetti A; De Renzo A; Di Gennaro F; Catalano L; Califano C; Pace L; Rotoli B; Salvatore M
    Eur J Nucl Med; 2001 Feb; 28(2):214-20. PubMed ID: 11303893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m sestamibi scanning in multiple myeloma stem cell transplantation.
    Look RM; Lim SW; Waxman AD; Gupta PK; Fuerst MM; Kusuanco DA; Lawrence GN; Giles FJ
    Leuk Lymphoma; 1996 Feb; 20(5-6):453-6. PubMed ID: 8833402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
    Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
    Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
    Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
    Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between Tc-99m sestamibi uptake and biological factors in hyperparathyroidism.
    Cermik TF; Puyan FO; Sezer A; Firat MF; Berkarda S
    Ann Nucl Med; 2005 Jul; 19(5):387-92. PubMed ID: 16164195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma.
    Del Vecchio S; Zannetti A; Aloj L; Caracò C; Ciarmiello A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):879-87. PubMed ID: 12721767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.